Olympus Partners-backed PAI Pharma strikes deal for Nexus Pharmaceuticals
Monday, November 16, 2026 · first reported by PEI Private Equity
Olympus Partners-backed PAI Pharma has struck a deal for Nexus Pharmaceuticals.
- Firm
- Olympus Partners
- Also named
- PAI Pharma, Nexus Pharmaceuticals
- Asset class
- Private equity
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
- KKR-led consortium pays $10b in cash for majority stake in Sempra Infrastructure PartnersIREI
- Blackstone Digital Infrastructure Trust, AWS Form $5B data center Joint ventureCommercial Observer +3
- Diamondback nears $5bn acquisition of EnCap-backed Permian assetsPrivate Equity Wire
- Mubadala and Centerbridge acquire Canaccord Wealthpaperjam.lu +2
- Brookfield and KKR compete for $700m Gulf eyewear retailer EyewaPrivate Equity Wire
- GSA forms $792m U.K. student housing JVIREI +1
Got news? Send it to us →